NCT02129660 - Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis | Biotech Hunter

Enrollment

105

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions

Hyperhidrosis

Interventions

DRUG

Dose 1 of glycopyrrolate, 2.0% QD

Dose 1 of glycopyrrolate Topical Wipes

DRUG

Dose 2 of glycopyrrolate, 3.0% QD

Dose 2 of glycopyrrolate Topical Wipes

DRUG

Dose 1 of glycopyrronium, 2.5% QD

Dose 1 of glycopyrronium Topical Wipes

DRUG

Dose 2 of glycopyrronium, 3.75% QD

Dose 2 of glycopyrronium Topical Wipes

OTHER

Vehicle

Vehicle Topical Wipes

Trial Locations (15)

23507

Virginia Clinical Research, Inc., Norfolk

33401

Kenneth R. Beer MD, West Palm Beach

33609

Olympian Clinical Research, Tampa

37072

Rivergate Dermatology Clinical Research Center, PLLC, Goodlettsville

44122

Haber Dermatology and Cosmetic Surgery, Beachwood

46032

Shideler Clinical Research Center, Carmel

63122

Saint Louis University Dermatology, St Louis

78759

DermResearch, Inc, Austin

84117

Dermatology Research Center, Inc., Salt Lake City

92024

California Dermatology & Clinical Research Institute, Encinitas

94538

Center For Dermatology Clinical Research, Fremont

98101

Dermatology Associates, Seattle

98105

Women's Clinical Research Center, Seattle

99204

Premier Clinical Research, Spokane

H2K 4L5

Innovaderm Research Inc., Montreal